Panhematin 350 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FCZC2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,858
Award facts
- Contract value 100% obligated
- $30,857.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $30,857.64 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Panhematin 350 mg vials. This delivery order, awarded on December 16, 2025, with an ultimate completion date of January 8, 2026, requires no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal pharmaceutical procurement. DMS Pharmaceutical Group serves as the sole awardee with no identified subcontractors.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, awarded on November 13, 2025, with a $499.999 billion ceiling value extending through December 31, 2036. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to establish regional prime vendor contractors supplying comprehensive pharmaceutical products to Department of Defense military healthcare facilities worldwide. As one of multiple regional prime vendors under this strategic program, DMS Pharmaceutical Group provides branded and generic prescription drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support recurring medical supply needs across the global military medical system.
Quick answers
Who was awarded contract SPE2DR26FCZC2?
SPE2DR26FCZC2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FCZC2 worth?
The government has obligated $30,858 on SPE2DR26FCZC2.
Is contract SPE2DR26FCZC2 an order under another contract?
Yes. SPE2DR26FCZC2 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCZC2 competed?
The extent of competition for SPE2DR26FCZC2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award